ReportGem ReportGem 中文

REAL-TIME GLOBAL RESEARCH

Genesis Minerals/Regis Resources: GMD interlopes for Vault; stronger logic than RRL/VAU and accretive on risked synergies

Published: 2026-07-06Institution: JPMorganPages: 18Original language: EnglishEvidence page: 1

Research evidence excerpt

Genesis Minerals/Regis Resources: GMD interlopes for Vault; stronger logic than RRL/VAU and accretive on risked synergies

J P M O R G A N Asia Pacific Equity Research

06 July 2026

Genesis Minerals/Regis

Resources

GMD interlopes for Vault; stronger logic than RRL/VAU

and accretive on risked synergies

GMD has delivered a binding superior proposal to acquire Vault, offering 0.7629 Australia

GMD shares plus A$0.475 cash per VAU share. This implies A$5.27/sh, valuing

Metals & Mining

Vault equity at ~A$5.6bn, a 14.5% premium to the mark-to-market RRL offer and

17.2% to Vault’s undisturbed price. Vault has deemed the proposal superior, with Jonathon Sharp AC

Regis’s matching right expiring 13 July. Key takeaways: 1) the strategic logic (61 2) 9003-8312

jonathon.sharp@jpmorgan.com

looks stronger than RRL/VAU given the proximity of KOTH, Tower Hill and J.P. Morgan Securities Australia Limited

Laverton, with GMD using higher-rated scrip to acquire a lower-multiple earnings Lyndon Fagan

base; 2) the deal screens ~33% EPS accretive in FY28, including only A$50m of (61-2) 9003-8648

post-tax synergies, but fades to broadly neutral in FY29 as GMD’s own earnings lyndon.fagan@jpmorgan.com

step up; and 3) while GMD discloses ~A$1.5bn of synergies, we risk-weight the J.P. Morgan Securities Australia Limited

number rather than give full credit upfront. Even on risked synergies, the deal still Branko Skocic

looks accretive. We retain OW on GMD; A$7.40 PT. (61-3) 9633-4069

branko.skocic@jpmorgan.com

• Deal / structure. VAU shareholders receive 0.7629 GMD shares plus A$0.475 J.P. Morgan Securities Australia Limited

cash/sh and would own ~40% of the enlarged group, with GMD shareholders Devwrat Vegad

owning ~60%. The offer is not subject to financing or due diligence. The (91-22) 6157-3608

The English excerpt is extracted automatically from the cited source page and may contain layout or recognition errors. It is never batch translated.

Open report viewer